Cost minimization analysis of two chemotherapy regimens in the treatment of colorectal cancer in a public reimbursement hospital in Brazil

Objective: To conduct a pharmacoeconomic evaluation between XELOX and mFOLFOX6 in the adjuvant and metastatic treatment of colorectal cancer from the perspective of a public reimbursement hospital. Methods: The cost minimization analysis was conducted for patients who started treatment in 2013 and...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Sara C. BOSCATO, Márcia R. GODOY, Isabela HEINECK
Format: article
Langue:EN
PT
Publié: Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde 2021
Sujets:
Accès en ligne:https://doaj.org/article/dcac267a47ea48cb9ed155b9b1f77a35
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!